These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3966920

  • 21. Mechanism for acivicin inactivation of triad glutamine amidotransferases.
    Chittur SV, Klem TJ, Shafer CM, Davisson VJ.
    Biochemistry; 2001 Jan 30; 40(4):876-87. PubMed ID: 11170408
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
    Meck RA, Clubb KJ, Allen LM, Yunis AA.
    Cancer Res; 1981 Nov 30; 41(11 Pt 1):4547-53. PubMed ID: 7306976
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of inactivation of glutamine amidotransferases by the antitumor drug L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
    Tso JY, Bower SG, Zalkin H.
    J Biol Chem; 1980 Jul 25; 255(14):6734-8. PubMed ID: 6993476
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.
    McGovren JP, Pratt EA, Belt RJ, Taylor SA, Benjamin RS, Ardalan B, Ohnuma T.
    Cancer Res; 1985 Sep 25; 45(9):4460-3. PubMed ID: 3896481
    [Abstract] [Full Text] [Related]

  • 26. Acivicin. An antitumor antibiotic.
    Poster DS, Bruno S, Penta J, Neil GL, McGovren JP.
    Cancer Clin Trials; 1981 Sep 25; 4(3):327-30. PubMed ID: 7026076
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.
    Kensler TW, Reck LJ, Cooney DA.
    Cancer Res; 1981 Mar 25; 41(3):905-9. PubMed ID: 7459876
    [No Abstract] [Full Text] [Related]

  • 28. The glutamine hydrolysis function of human GMP synthetase. Identification of an essential active site cysteine.
    Nakamura J, Straub K, Wu J, Lou L.
    J Biol Chem; 1995 Oct 06; 270(40):23450-5. PubMed ID: 7559506
    [Abstract] [Full Text] [Related]

  • 29. Effect of acivicin on glutamine transport by rat renal brush border membrane vesicles.
    Sastrasinh S, Sastrasinh M.
    J Lab Clin Med; 1986 Oct 06; 108(4):301-8. PubMed ID: 2876045
    [Abstract] [Full Text] [Related]

  • 30. Purine enzymology of human colon carcinomas.
    Natsumeda Y, Lui MS, Emrani J, Faderan MA, Reardon MA, Eble JN, Glover JL, Weber G.
    Cancer Res; 1985 Jun 06; 45(6):2556-9. PubMed ID: 3986794
    [Abstract] [Full Text] [Related]

  • 31. Glutamine-dependent carbamoyl-phosphate synthetase and other enzyme activities related to the pyrimidine pathway in spleen of Squalus acanthias (spiny dogfish).
    Anderson PM.
    Biochem J; 1989 Jul 15; 261(2):523-9. PubMed ID: 2570570
    [Abstract] [Full Text] [Related]

  • 32. The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
    Allen L, Meck R, Yunis A.
    Res Commun Chem Pathol Pharmacol; 1980 Jan 15; 27(1):175-82. PubMed ID: 6102405
    [Abstract] [Full Text] [Related]

  • 33. Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
    Mukherjee T, Roy K, Bhaduri A.
    Biochem Biophys Res Commun; 1990 Jul 31; 170(2):426-32. PubMed ID: 2383250
    [Abstract] [Full Text] [Related]

  • 34. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
    Jayaram HN, Cooney DA, Ryan JA, Neil G, Dion RL, Bono VH.
    Cancer Chemother Rep; 1975 Jul 31; 59(3):481-91. PubMed ID: 1147
    [Abstract] [Full Text] [Related]

  • 35. Action of insulin on liver carbamoyl-phosphate synthetase II (glutamine-hydrolyzing) activity.
    Reardon MA, Weber G.
    Biochem Biophys Res Commun; 1983 Jul 18; 114(1):255-60. PubMed ID: 6349626
    [Abstract] [Full Text] [Related]

  • 36. Hepatic carbamoyl phosphate metabolism. Role of cytosolic and mitochondrial carbamoyl phosphate in de novo pyrimidine synthesis.
    Pausch J, Rasenack J, Häussinger D, Gerok W.
    Eur J Biochem; 1985 Jul 01; 150(1):189-94. PubMed ID: 4018077
    [Abstract] [Full Text] [Related]

  • 37. Enzyme targets of antiglutamine agents in cancer chemotherapy.
    Prajda N.
    Adv Enzyme Regul; 1985 Jul 01; 24():207-23. PubMed ID: 2424283
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G, Natsumeda Y, Lui MS, Faderan MA, Liepnieks JJ, Elliott WL.
    Adv Enzyme Regul; 1984 Jul 01; 22():69-93. PubMed ID: 6206692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.